You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Worldwide access to treatment for end-stage kidney disease: a systematic review
|
|---|---|
| Published in |
The Lancet, March 2015
|
| DOI | 10.1016/s0140-6736(14)61601-9 |
| Pubmed ID | |
| Authors |
Thaminda Liyanage, Toshiharu Ninomiya, Vivekanand Jha, Bruce Neal, Halle Marie Patrice, Ikechi Okpechi, Ming-hui Zhao, Jicheng Lv, Amit X Garg, John Knight, Anthony Rodgers, Martin Gallagher, Sradha Kotwal, Alan Cass, Vlado Perkovic |
X Demographics
The data shown below were collected from the profiles of 93 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 12 | 13% |
| United Kingdom | 7 | 8% |
| Canada | 6 | 6% |
| India | 6 | 6% |
| Australia | 4 | 4% |
| Sweden | 3 | 3% |
| Ireland | 2 | 2% |
| Kenya | 2 | 2% |
| Spain | 2 | 2% |
| Other | 12 | 13% |
| Unknown | 37 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 67 | 72% |
| Practitioners (doctors, other healthcare professionals) | 13 | 14% |
| Scientists | 11 | 12% |
| Science communicators (journalists, bloggers, editors) | 2 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 1,453 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Malaysia | 2 | <1% |
| Australia | 2 | <1% |
| Japan | 2 | <1% |
| South Africa | 1 | <1% |
| Norway | 1 | <1% |
| Guatemala | 1 | <1% |
| India | 1 | <1% |
| Unknown | 1443 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 201 | 14% |
| Student > Bachelor | 162 | 11% |
| Researcher | 140 | 10% |
| Student > Ph. D. Student | 136 | 9% |
| Student > Postgraduate | 104 | 7% |
| Other | 252 | 17% |
| Unknown | 458 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 486 | 33% |
| Nursing and Health Professions | 133 | 9% |
| Biochemistry, Genetics and Molecular Biology | 50 | 3% |
| Engineering | 49 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 34 | 2% |
| Other | 200 | 14% |
| Unknown | 501 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 379. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 April 2024.
All research outputs
#83,578
of 25,728,855 outputs
Outputs from The Lancet
#1,270
of 42,966 outputs
Outputs of similar age
#817
of 277,444 outputs
Outputs of similar age from The Lancet
#11
of 550 outputs
Altmetric has tracked 25,728,855 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 42,966 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 68.1. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 277,444 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 550 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.